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Associations of adult measures of childhood growth with breast
cancer : findings from the British Women’s Heart and Health Study
DA Lawlor*,1, M Okasha1, D Gunnell1, G Davey Smith 1 and S Ebrahim1
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Since the two components of adult height – leg length and trunk length – are poorly correlated with each other and appear to be
influenced by different early life factors, examining their separate influence on breast cancer may provide additional insights into the
mechanisms responsible for the positive association between adult height and breast cancer. In a cross-sectional study of 4286
women aged 60–79 years, in whom there were 170 cases of breast cancer, we found total height, leg length and trunk length were
all modestly positively and linearly associated with breast cancer. The magnitudes of the associations of leg and trunk length were
similar: fully adjusted odds ratio (95% confidence interval) of breast cancer for a one standard deviation (s.d.) increase in leg length
1.17 (0.98, 1.39) and for a 1 s.d. increase in trunk length 1.19 (0.99, 1.41). Self-reported birth weight (available on 33% of the sample)
was positively and linearly associated with breast cancer: fully adjusted odds ratio of breast cancer for a 1 s.d. increase in birth weight
1.30 (0.93, 1.80). These associations were all independent of each other and other potential confounding factors and are likely to
reflect different mechanisms by which factors operating prenatally and prepubertally influence breast cancer risk.
British Journal of Cancer (2003) 89, 81–87. doi:10.1038/sj.bjc.6600972 www.bjcancer.com
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Ecological studies of breast cancer have shown that geographic
variations in incidence and mortality are associated with variations
in population height (Barker et al, 1990; Albanes and Taylor,
1990). The majority of cohort studies have found that tall stature is
associated with increased cancer risk. The most consistent
associations are found for breast cancer, a recent review finding
that all but one (Davey Smith et al, 2000) of 24 prospective studies
showed a positive association with height (Gunnell et al, 2001).
The underlying mechanisms for the association between tall
stature and breast cancer risk are not understood. The association
may be explained by factors that jointly influence stature and
breast cancer risk. These include hormones such as insulin-like-
growth factor I (IGF-I) (Hankinson et al, 1998; Kaaks et al, 2002),
energy intake in childhood (McCay et al, 1939; Hart and Turturro,
1997; Frankel et al, 1998), and also intrauterine growth, reflected
by birth weight, which has been found to be positively associated
with breast cancer risk (Michels et al, 1996; Stavola et al, 2000;
Vatten et al, 2002). Since the two components of adult height – leg
length and trunk length – are poorly correlated with each other
and appear to be influenced by different early life factors (Gunnell,
2002; Wadsworth et al, 2002), examining their separate associa-
tions with breast cancer may provide additional insights into the
mechanisms responsible for the association between height and
breast cancer. Three case–control studies have reported incon-
sistent findings in the associations between components of height
and breast cancer (Brinkley et al, 1971; Mondina et al, 1992;
Swanson et al, 1996). One prospective cohort study found modest
associations between both leg length and trunk length (Albanes
et al, 1988), whereas a second found an association with leg length
only, but this was based on six cases of breast cancer (Gunnell et al,
1998). The aim of this study is to investigate the associations of
self-reported birth weight and adult anthropometric indicators of
childhood growth with breast cancer.
METHODS
Participants
The British Women’s Heart and Health Study comprises 4286 (60%
of those invited to participate) women aged 60–79 years randomly
selected from general practitioner lists of 23 British towns.
Selection of towns, general practitioners (GPs) and participants
was based on the methods used for the British Regional Heart
Study of men (Shaper et al, 1981). Ethics committee approvals
were obtained for the study and consent to access medical records
and to flag the women with the National Health Service Cancer
Register (NHSCR) were obtained from the participants. Partici-
pants completed a questionnaire and attended a local health centre
where a research nurse interview, physical examination and blood
sampling were undertaken. General practitioner (primary care)
medical records were reviewed for each participant and details of
diagnoses of cardiovascular disease, diabetes and cancers were
extracted by reviewing written general practice records, hospital
letters and computerised medical records. Data were collected
between April 1999 and March 2001 and full details of methods
have been previously reported (Lawlor et al, 2002).
Measurements
Standing and seated heights were measured to the nearest
millimetre, without shoes, using a Harpenden Stadiometer. Trunk
length was calculated as the seated height minus the height of the
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stool (407 mm). Leg length was taken as the standing height minus
the trunk length. Weight was measured in light clothing without
shoes to the nearest 0.1 kg using Soenhle portable scales. Waist
circumference was taken as the midpoint between the lower rib
and the iliac crest. Hip circumference was taken as the largest
circumference below the waist.
Three sources of data were used to determine breast cancer
status: (i) women were asked if they had ever been told by a doctor
that they had breast cancer and, if so, the date of diagnosis; (ii)
diagnoses of breast cancer together with dates were extracted from
the general practitioner medical records (including written
records, computer records and hospital correspondence); and
(iii) all participants were flagged with the National Health Service
Central Register (NHSCR), which provided details of cancer
registrations. Anyone with a diagnosis of breast cancer from any
one of these three sources was considered to be a prevalent case.
Flagging of participants with the NHSCR was continuous, and is
still ongoing, from the time of the baseline fieldwork (completed in
March 2001). We included all cases from the NHSCR that were
reported to us by the NHSCR up to November 2002 (the time of the
current analyses) and that had been diagnosed prior to the date
that the woman attended for baseline study examination. Cases
were defined as pre- and postmenopausal based on self-report of
age at menopause and the date of first diagnosis of breast cancer
obtained from the GP record, cancer register or, if not available
from these two sources, self-report (n¼ 11). For women who had
had an oophorectomy prior to their natural menopause, the date of
the oophorectomy was taken as their date of menopause. For
women who had had a hysterectomy without oophorectomy prior
to their natural menopause, their age of menopause was assumed
to be the median of the cohort – 50 years (n¼ 11 breast cancer
cases), and for women with breast cancer who did not provide
details of their age at menopause, their age at menopause was
assigned 50 years (n¼ 3). The women were asked to report their
birth weight in pounds (lb) and ounces (oz) in the self-completed
questionnaire; they were not given the option of providing birth
weight in prespecified categories. For comparisons with other
studies, the self-reported birth weights were converted from lb to
kg by multiplying by a factor of 0.4545.
Statistical analysis
Pearson’s correlation coefficients were used to assess associations
between total height and components of height. To illustrate the
direction and shape of associations, age-adjusted means and
prevalences of breast cancer and possible confounding factors
were estimated across quarters of height and each component of
height. These were estimated using multiple linear and logistic
regression models with the age variable centred around the mean
age value. Multiple logistic regression was used to assess the
associations of the various anthropometric measures with breast
cancer prevalence, with adjustment for potential confounding or
intermediary variables. In these models, age, age at menarche, age
at menopause, weight, waist-to-hip ratio and birth weight were
entered as continuous variables. Osteoporosis (yes, no), hyster-
ectomy and/or oopherectomy (yes, no) adult and childhood social
class (I, II, III nonmanual, III manual, IV, V) and smoking (never,
ex- and current) were entered as dummy variables. Of the 4286
women, 425 could not be assigned an adult social class and 545
could not be assigned to a childhood social class because they did
not provide data on occupation. Although the participants were
not specifically asked about unemployment, these women are
likely to have been married to unemployed men (for those with
missing adult data) and had fathers who were unemployed (for
those with missing childhood data). This is consistent with the
findings that women without these data on social class were more
likely to smoke, more likely to be obese, were shorter and were
more likely to have prevalent coronary heart disease than cohort
members who provided these data (Lawlor et al, 2002). In the main
analysis, women with missing social class data were allocated to
social class V, the most deprived group. A sensitivity analysis was
conducted in which these women were excluded from the analysis.
These results did not differ substantively from the main analyses
and have not been presented in this paper. There were missing
data on age at menarche (n¼ 405), age at menopause (n¼ 280),
smoking (n¼ 19) and osteoporosis (n¼ 476). In all multiple
logistic regression models, only those with complete data on all
variables (n¼ 3554) included in the fully adjusted model were
included in each simpler model. In all analyses, robust standard
errors taking into account possible nonindependence between
women from the same town were used to estimate confidence
intervals.
RESULTS
The prevalence of breast cancer among women who were invited to
take part in the study but did not respond was obtained from GP
record reviews – the proportion of general practice recorded
breast cancer did not differ between responders and non-
responders (3.1% (95% confidence interval 2.6, 3.7%) vs 2.8%
(2.2, 3.5%), P¼ 0.7). In total, 170 of the participants had a
diagnosis of breast cancer from at least one source, giving an
overall prevalence of 4.0% (3.4, 4.6%). The majority (87%) of these
cases were identified from at least two sources. The age
distributions of women with cancer identified by each source
were similar – mean (standard deviation) age of women with
breast cancer identified by self-report 68.5 (5.3), identified by
medical record review 68.4 (5.3) and identified by cancer register
68.6 (5.3). Of the 170 cases, 39 (22.9%) were premenopausal and
131 (77.1%) were postmenopausal.
While both leg length and trunk length were strongly correlated
with total height (age-adjusted Pearson’s correlation coefficients
0.80 (95% confidence interval 0.78, 0.82) and 0.76 (0.74, 0.79)
respectively), leg length and trunk length were only weakly
correlated with each other (r¼ 0.24 (0.21, 0.27)). The weak
correlation between the two components of height justifies
considering their roles in the association between height and
disease outcome separately.
Table 1 shows age-adjusted breast cancer prevalence and other
characteristics of the participants across quarter of components of
height. Breast cancer prevalence shows a graded linear increase
with increasing height, leg length and trunk length. Women with
shorter legs were younger at menarche. Both shorter trunk length
and shorter leg length appear to be associated with younger age at
menopause, although the association with trunk length was more
consistent across all four quarters. Current smokers and women
with osteoporosis had shorter trunk lengths, but neither smoking
nor osteoporosis was associated with leg length. Belonging to a
manual social class in both adulthood and childhood was
associated with reduced lengths of both components of height,
but differences were greater for leg length. Birth weight was
positively associated with total height, leg length and trunk length.
Table 2 shows the odds ratios for breast cancer associated with
each component of height with adjustment for potential con-
founding factors; these analyses are based on 145 cases of breast
cancer among 3554 women with complete data on all variables
included in the fully adjusted model. There was no difference in
the prevalence of breast cancer between women with complete data
on all variables included in these analyses and all women in the
cohort (4.1 vs 4.0%, P¼ 0.72). After adjustment for age, smoking,
weight, waist-to-hip ratio, age at menarche, age at menopause,
osteoporosis, adult social class and childhood social class, a 1 s.d.
increase in total height was associated with an increased odds of
prevalent breast cancer: 1.25 (1.04, 1.50). Both leg length and trunk
length were associated with increased odds of prevalent breast
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Table 1 Age-adjusted means or prevalences (95% confidence interval) of breast cancer and other characteristics by quartiles of components of height
(n¼ 4286a)
Height quartile (range of height in cm)
1 (115.2–154.7) 2 (154.8–158.7) 3 (158.8–162.8) 4 (162.9–189.9) P trend
Age (years) 70.3 (69.9, 70.6) 69.1 (68.8, 69.5) 68.1 (68.1, 68.8) 67.3 (67.0, 67.6) o0.001
Breast cancer (%) 2.8 (1.9, 4.1) 3.9 (2.8, 5.3) 4.8 (3.6, 6.3) 4.8 (3.6, 6.4) 0.03
Age at menarche (years) 13.2 (13.1, 13.3) 13.3 (13.2, 13.4) 13.4 (13.3, 13.5) 13.5 (13.4, 13.6) o0.001
Age at menopause (years) 47.7 (47.3, 48.1) 48.2 (47.9, 48.6) 48.1 (47.7, 48.4) 48.6 (48.2, 49.0) 0.02
Osteoporosis (%) 10.7 (8.8, 12.9) 9.2 (7.5, 11.3) 8.9 (7.2, 10.9) 6.6 (5.1, 8.4) 0.006
Weight (kg) 65.0 (64.2, 65.8) 68.7 (67.9, 69.5) 70.5 (69.7, 71.2) 74.4 (73.6, 75.2) o0.001
Waist : hip ratio 0.822 0.821 0.818 0.815 0.02
(0.818, 0.826) (0.817, 0.825) (0.814, 0.822) (0.811, 0.819)
Current smoker (%) 13.4 (11.4, 15.6) 10.8 (9.0, 12.8) 9.3 (7.6, 11.2) 10.0 (8.3, 12.1) o0.001
Adult manual social class (%) 57.6 (54.2, 60.9) 51.6 (48.3, 54.9) 49.9 (46.6, 53.2) 44.4 (41.1, 47.7) o0.001
Childhood manual social class (%) 82.4 (79.7, 84.9) 77.3 (74.4, 79.9) 76.5 (73.6, 79.1) 69.7 (66.5, 72.7) o0.001
Birth weight (kg) 2.98 (2.89, 3.07) 3.24 (3.15, 3.30) 3.34 (3.26, 3.42) 3.51 (3.43, 3.59) o0.001
Leg length quartile (range of leg length in cm)
1 (49.8–73.1) 2 (73.2–75.7) 3 (75.8–78.3) 4 (78.4–100.7) P trend
Age (years) 69.1 (68.8, 69.5) 68.9 (68.6, 69.2) 68.7 (68.4, 69.1) 68.4 (68.1, 68.8) 0.02
Breast cancer (%) 3.3 (2.3, 4.6) 4.1 (3.0, 5.5) 3.3 (2.3, 4.7) 5.5 (4.2, 7.2) 0.13
Age at menarche (years) 13.1 (13.0, 13.2) 13.3 (13.2, 13.4) 13.4 (13.3, 13.5) 13.5 (13.4, 13.6) o0.001
Age at menopause (years) 48.1 (47.7, 48.5) 48.0 (47.6, 48.3) 47.9 (47.6, 48.3) 48.6 (48.2, 48.9) 0.06
Osteoporosis (%) 8.3 (6.7, 10.3) 8.7 (7.0, 10.7) 9.5 (7.7, 11.6) 8.7 (7.0, 10.7) 0.99
Weight (kg) 67.6 (66.8, 64.8) 68.5 (67.7, 69.3) 70.3 (69.4, 71.0) 72.1 (71.3, 72.9) o0.001
Waist : hip ratio 0.818 0.821 0.820 0.817 0.96
(0.813, 0.822) (0.817, 0.826) (0.816, 0.825) (0.812, 0.821)
Current smoker (%) 11.7 (9.9, 13.9) 12.0 (10.1, 14.2) 8.6 (7.0, 10.5) 11.3 (9.5, 13.5) 0.55
Adult manual social class (%) 58.1 (54.8, 61.4) 51.6 (48.3, 54.9) 47.0 (43.7, 50.3) 46.4 (43.2, 49.7) o0.001
Childhood manual social class (%) 84.2 (81.6, 86.5) 76.1 (73.1, 78.8) 75.9 (72.9, 78.7) 69.5 (66.4, 72.5) o0.001
Birth weight (kg) 3.03 (2.94, 3.12) 3.23 (3.14,3.32) 3.56 (3.28, 3.44) 3.47 (3.39, 3.55) o0.001
Trunk length quartile (range of trunk length in cm)
1 (64.9–80.7) 2 (80.8–83.0) 3 (83.1–85.4) 4 (85.5–112.0) P trend
Age (years) 70.9 (70.6, 71.3) 69.4 (69.0, 69.7) 68.0 (67.7, 68.4) 66.8 (66.5, 67.1) o0.001
Breast cancer (%) 3.0 (2.1, 4.3) 4.6 (3.5, 6.2) 3.8 (2.7, 5.2) 4.8 (3.6, 6.4) 0.07
Age at menarche (years) 13.3 (13.2, 13.4) 13.3 (13.2, 13.4) 13.3 (13.2, 13.4) 13.4 (13.2, 13.5) 0.33
Age at menopause (years) 47.7 (47.3, 48.1) 48.1 (47.7, 48.5) 48.4 (48.0, 48.7) 48.3 (47.9, 48.7) 0.01
Osteoporosis (%) 13.1 (11.0, 15.5) 8.6 (6.9, 10.6) 7.0 (5.5, 8.8) 6.8 (5.3, 8.7) o0.001
Weight (kg) 64.1 (63.3, 64.9) 68.2 (67.4, 68.9) 71.2 (70.4, 72.0) 75.2 (74.4, 76.0) o0.001
Waist : hip ratio 0.827 0.816 0.816 0.816 o0.001
(0.823, 0.832) (0.812, 0.820) (0.812, 0.821) (0.811, 0.820)
Current smoker (%) 12.5 (10.6, 14.7) 11.6 (9.8, 13.8) 10.4 (8.7, 12.4) 8.9 (7.2, 10.8) o0.001
Adult manual social class (%) 54.1 (50.7, 57.4) 51.5 (48.2, 54.8) 49.6 (46.4, 52.8) 48.0 (44.7, 51.3) 0.008
Childhood manual social class (%) 79.1 (76.2, 81.7) 77.5 (74.6, 80.2) 73.7 (70.7, 76.5) 75.5 (72.4, 78.3) 0.004
Birth weight (kg) 3.05 (2.96, 3.15) 3.20 (3.11, 3.29) 3.32 (3.24, 3.41) 3.50 (3.41, 3.58) o0.001
aFor age at menarche based on 3881 participants; age at menopause 4006 participants; osteoporosis 3811 participants; smoking 4267 participants and birth weight 1394
participants.
Table 2 Odds ratios (95% Confidence intervals) of breast cancer prevalence for a 1 s.d. increase in height,
leg length and trunk length
Age-adjusted
OR (95% CI)
Age, lifestyle and
reproductive factor
adjusteda OR (95% CI)
Age, lifestyle, reproductive
factor and lifecourse
socioeconomic position
adjustedb OR (95% CI)
Height 1.24 (1.04, 1.48) 1.25 (1.04, 1.49) 1.25 (1.05, 1.50)
Leg length 1.15 (0.96, 1.35) 1.17 (0.98, 1.39) 1.17 (0.98, 1.39)
Trunk length 1.21 (1.00, 1.46) 1.19 (0.99, 1.41) 1.19 (0.99, 1.41)
All analyses included in the table are based only on those with complete data for all variables in final model – 3554 with 145
breast cancer cases. OR¼ odds ratio CI¼ confidence interval; 1 s.d.¼ 1 standard deviation leg length¼ 4.3 cm, trunk
length¼ 3.6 cm, height¼ 6.4 cm. aAdjusted for age, smoking, weight, waist-to-hip ratio, age at menarche, age at menopause,
hysterectomy/oopherectomy, osteoporosis. bAdjusted for age, smoking, weight, waist-to-hip ratio, age at menarche, age at
menopause, hysterectomy/oopherectomy, osteoporosis, adult social class, childhood social class.
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cancer, with the magnitude of the associations being similar for
both components of height: fully adjusted odds ratio (95%
confidence interval) for 1 s.d. increase in leg length 1.17 (0.98,
1.39) and for 1 s.d. of trunk length 1.19 (0.99, 1.41). Since age at
menarche is associated with height and breast cancer, this could
potentially act as an important confounder or explanatory factor.
However, adjustment for menarcheal age alone did not impor-
tantly influence the associations between total height or any of the
components of height and breast cancer. With additional mutual
adjustment of leg length for trunk length and vice-versa both
components of height remained independently associated with
breast cancer prevalence: fully adjusted (including trunk length)
odds ratio for breast cancer prevalence with 1 s.d. increase in leg
length 1.14 (0.96, 1.37) and fully adjusted (including leg length)
odds ratio for breast cancer prevalence with 1 s.d. increase in trunk
length 1.16 (0.96, 1.39). To assess possible selection bias arising
through missing data, we estimated age-adjusted odds ratios for
each anthropometric variable in the complete data set. The age-
adjusted odds ratios for all women (total height: 1.23 (1.05, 1.45);
leg length: 1.14 (0.99, 1.34); and trunk length 1.19 (1.01, 1.37)) were
similar to those presented in Table 2 for women with complete
data included in the multivariable model.
When these associations were examined separately for premeno-
pausal and postmenopausal cancers, there were no associations
between height or each component of height and pre-menopausal
cancer, but total height, leg length and trunk length were all
positively associated with postmenopausal breast cancer (Table 3).
In these analyses to avoid contamination, we compared women
with premenopausal cancer to women without cancer (i.e. we did
not include women with postmenopausal cancers in the analysis)
and similarly for the analysis concerning postmenopausal cancers
the reference group was women with no evidence of breast cancer.
Of the 4286 participants, 1394 (33%) provided details of their
birth weight. There were no differences in prevalent breast cancer
between women who provided details of their birth weight and
those who did not (3.7% (2.8, 4.9%) vs 4.1% (3.5, 5.0%), P¼ 0.3).
The mean (s.d.) of self-reported birth weights in this cohort was
3.28 (0.80) kg. Self-reported birth weight was weakly positively
associated with both leg length and trunk length – age-adjusted
Pearson’s partial correlation coefficient for the association between
birth weight and leg length 0.15 (0.11, 0.19) and between birth
weight and trunk length 0.16 (0.11, 0.02). In this subgroup of
women with data on birth weights, birth weight was positively
associated with breast cancer prevalence – age-adjusted odds ratio
(95% confidence interval) of breast cancer for a 1 s.d. (0.80 kg)
increase in birth weight was 1.33 (0.96, 1.83). The association was
only slightly attenuated in fully adjusted models: 1.30 (0.93, 1.79).
Additional adjustment for height had little effect: 1.29 (0.93, 1.79).
Adjustment for birth weight did not significantly alter the
associations between total height and components of height with
breast cancer (Table 4). The fully adjusted (but without birth
weight) association between 1 s.d. of height and breast cancer was
1.15 (0.83, 1.58) in this subgroup; addition of birth weight to the
model did not change this estimate. Similarly, the odds ratio for
the association between leg length and breast cancer was
unchanged by adjustment for birth weight. The association
between trunk length and breast cancer was slightly attenuated
by adjustment for birth weight from 1.20 (0.89, 1.63) to 1.16 (0.84,
1.59), but remained positively associated.
When all analyses were repeated using breast cancer data from
each of just one of the three sources (cancer register, general
practice medical records, self-report), the results were unchanged.
Since socioeconomic position is strongly associated with adult
height, we repeated the multivariable analyses with different
indicators of socioeconomic position in childhood (car access and
bedroom sharing) and adulthood (car access and housing tenure)
and found no difference to the multivariable results presented in
Tables 2, 3 or 4.
DISCUSSION
In this study, adult height, leg length, trunk length and birth
weight were all modestly and positively associated with breast
cancer. The magnitude of the association between total height and
breast cancer was similar to that found in a number of prospective
cohort studies (Gunnell et al, 2001). In one prospective study that
looked at the associations of leg and trunk lengths with breast
cancer incidence, the fully adjusted odds ratio comparing the top
quarter of leg length to the bottom quarter was 1.6 (1.0, 2.6) and
that comparing the top quarter of trunk length to the bottom
quarter was 1.3 (0.7, 2.2) (Albanes et al, 1988). When we analyse
our data using a similar approach, the two studies are consistent
with each other: odds ratio comparing top to bottom quarter of leg
length in our study, 2.0 (1.2, 3.3), and comparing top to bottom
quarter of trunk length, 1.8 (1.0, 3.2). We found that total height,
leg length and trunk length were associated with postmenopausal
breast cancers only. However, the small number of premenopausal
Table 3 Odds ratios (ORs) (95% confidence intervals (CIs)) of breast cancer prevalence for a 1 s.d.
increase in height, leg length and trunk length, with separate results for premenopausal and postmenopausal
breast cancer
Age-adjusted
OR (95% CI)
Age, lifestyle and
reproductive factor
adjusteda OR (95% CI)
Age, lifestyle,
reproductive
factor and lifecourse
socioeconomic position
adjustedb OR (95% CI)
Premenopausal cancers, n¼ 28
Height 0.95 (0.66, 1.37) 0.98 (0.68, 1.40) 0.99 (0.69, 1.41)
Leg length 0.93 (0.65, 1.33) 0.94 (0.65, 1.34) 0.95 (0.66, 1.46)
Trunk length 0.99 (0.68, 1.42) 1.00 (0.69, 1.42) 1.00 (0.69, 1.43)
Postmenopausal cancers, n¼ 117
Height 1.32 (1.09, 1.61) 1.33 (1.09, 1.62) 1.31 (1.07, 1.61)
Leg length 1.19 (0.99, 1.44) 1.23 (1.01, 1.49) 1.21 (1.00, 1.48)
Trunk length 1.29 (1.07, 1.55) 1.26 (1.04, 1.52) 1.23 (1.01, 1.51)
All analyses included in the table are based only on those with complete data for all variables in final model. For
premenopausal cancers, n¼ 3437 with 28 premenopausal breast cancer cases; for postmenopausal cancers, n¼ 3526 with
117 postmenopausal breast cancer cases. Women with premenopausal cancers compared to all women without any
cancer. Women with postmenopausal cancers compared to all women without any cancer. a,bSee Table 2.
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cases meant that these results were imprecise; other studies of the
height– breast cancer association have found no difference in the
associations between height and pre- and postmenopausal cancers
(Gunnell et al, 2001). The magnitude of the association between
birth weight and breast cancer in our study is also similar to that of
a prospective study (Stavola et al, 2000).
Study limitations
Our response rate (60%) is moderate but the prevalences of GP
recorded cases of breast cancer were similar between responders
and nonresponders in our study. Height is significantly affected by
socioeconomic position, but the social class distribution in our
study sample is similar to that found for the 1991 census (52%
manual social class in British Women’s Heart and Health Study vs
55% older adults in the 1991 census). Further, no indicator of
childhood or adulthood social class were found to confound our
results. Response bias is, therefore, unlikely to have had an
important effect on our results.
Our study is cross-sectional and one of the most important
limitations is survivor bias. Breast cancer in the UK is associated
with a survival rate of 70% over 5 years (Coleman et al, 1999). Our
study may, therefore, exclude a number of women with the most
aggressive form of breast cancer. This would have an important
effect on the results if height and the components of height were
associated with breast cancer survival. However, the one
prospective study that compared the association between both
height and breast cancer incidence and mortality found no
difference in the magnitude of the association, indicating no effect
of height on survival (Tretli, 1989). Reverse causality must also be
considered. Women with breast cancer may become shorter in the
trunk because of bone or lung metastases or treatment effects on
bone integrity, but this would create an inverse relation (not the
observed positive association) with breast cancer. Breast cancer is
unlikely to have an effect on leg length, and clearly will not affect
birth weight. The associations found in our study are all of a
similar magnitude to those found in prospective studies (Stavola
et al, 2000; Gunnell et al, 2001), suggesting that the cross-sectional
nature of our study has not significantly biased our results.
We used self-report of birth weight, which may be inaccurate,
although self-reported birth weight is strongly correlated with
hospital records among middle-aged and older women (Allen et al,
2002). Women in our study were born between 1919 and 1940 and
the mean self-reported birth weight for these women was 3.28 kg
(s.d. 0.80), which is consistent with hospital records of women
born between 1923 and 1930 in Hertfordshire, England (3.42 kg, no
s.d.) (Fall et al, 1995), and also with women in the 1946 British
cohort (3.32 kg, s.d. 0.49 – Dr D Kuh, personal communication).
Any misclassification bias is likely to have been nondifferential
and will therefore have diluted rather than exaggerated the
associations presented.
Explanations for the associations between leg length, trunk
length and birth weight with breast cancer
A number of factors may explain the associations between
measures of foetal and childhood growth and breast cancer.
Genetic factors could explain the association between growth and
cancer in two ways. First, genes important in the control of growth
may also produce mitogenic proteins. Second, there may be
linkage between genes regulating growth and cancer-causing
genes. As positive height– cancer associations have been reported
in dizygotic twins who were discordant for height, this suggestion
is unlikely, although firmer evidence is required from studies of
growth– cancer associations in monozygotic twins. Age at
menarche is closely related to patterns of growth and final height
(Okasha et al, 2002). The timing of exposure to the high levels of
sex hormones experienced during puberty may be related to breast
cancer risk. However, adjustment for age at menarche did not
substantially alter the associations between total height or either
component of height and breast cancer.
Leg length and trunk length are only weakly correlated with each
other and their associations with breast cancer are independent of
each other and other potential confounding factors. This suggests
that each component of height is likely to be associated with breast
cancer via different mechanisms. Table 5 summarises the possible
pathways underlying the growth – breast cancer associations, and
these are discussed in more detail below with respect to the specific
associations identified in this study.
Leg length
Leg length is an indicator of prepubertal environmental cir-
cumstances; the interruption of growth during childhood results
in short leg length (Gunnell, 2002). While a number of child-
hood factors, such as stress, infection and nutrition, may interrupt
growth and hence result in short legs, a detailed analysis of
the British 1946 birth cohort found that infant feeding was the
most important childhood factor associated with leg length
(Wadsworth et al, 2002). Animal studies have shown that energy
restriction leads to growth retardation and decreased risk of cancer
(McCay et al, 1939; Hankinson et al, 1998), and a study in humans
found that lower energy intake in childhood was associated with
reduced cancer risk in adulthood (Frankel et al, 1998). The
association between energy restriction in childhood and decreased
breast cancer risk in adulthood may be mediated via IGF, which
plays a fundamental role in somatic growth. Growth hormone
affects cellular growth through the actions of IGFs. Serum IGF
levels are also affected by diet (Okasha et al, 2002). In children
IGF-I levels are positively associated with stature, and during
pubertal growth periods IGF-I serum levels can be as high as four
times the normal adult concentration. In energy-restricted mice,
administration of IGF-I reverses their decreased cancer risk
(Petridou et al, 2000). However, in epidemiological studies
Table 4 Odds ratios (ORs) (95% confidence intervals (CIs)) of breast cancer prevalence for a 1 s.d.
increase in height, leg length, trunk length, leg to trunk length ratio with additional adjustment for birth weight
Age-adjusted
OR (95% CI)
Fully adjusted
(but without birth weight)a
OR (95% CI)
Fully and birth-weight-adjustedb
OR (95% CI)
Height 1.17 (0.85, 1.59) 1.15 (0.83, 1.58) 1.15 (0.83, 1.57)
Leg length 1.13 (0.83, 1.56) 1.14 (0.83, 1.57) 1.14 (0.85, 1.57)
Trunk length 1.23 (0.91, 1.66) 1.20 (0.89, 1.63) 1.16 (0.84, 1.59)
All analyses included in the table are based only on those with complete data for all variables in final model n¼ 1250 with
43 breast cancer cases. 1 s.d. 1 standard deviation leg length¼ 4.3 cm, trunk length¼ 3.6 cm, height¼ 6.4 cm. aAdjusted for
age, smoking, weight, waist-to-hip ratio, age at menarche, age at menopause, hysterectomy/oophorectomy, osteoporosis,
adult social class, childhood social class. bAdjusted for all variables included in footnote a and birth weight.
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inconsistent findings have been reported for the association
between IGF-I and breast cancer (Hankinson et al, 1998; Kaaks
et al, 2002).
Trunk length
Childhood illnesses lasting longer than 3 months in any year or
leading to a hospital admission are associated with shorter trunk
length (Wadsworth et al, 2002), suggesting that the association
between longer trunk length and breast cancer prevalence may
reflect reduced childhood infections. A lower number of infections
in childhood (resulting in longer trunk length) may lead to
increased cancer risk in two ways (Gunnell et al, 2001). First, it
may leave older children and adults susceptible to infections that,
if experienced in later life, carry a greater risk of malignancy. Late
childhood infection with Epstein –Barr virus and cytomegalovirus
may be implicated in breast cancer aetiology (Richardson, 1997;
Touitou et al, 2001). Second, it may lead to an underdevelopment
of immune function and hence an increase in cancer risk. It has
been shown that risk of lymphoma is increased among individuals
from small families and that small family size is, in turn, associated
with greater stature (Bonelli et al, 1990; Davey Smith et al, 2000).
In the US Nurses Health Study, women who were breastfed as
children, and therefore likely to have had fewer childhood
infections than those who were not, had a slightly increased risk
of breast cancer 1.11 (0.88, 1.39) (Michels et al, 2001), supporting
the hypothesis that childhood infections might protect against
breast cancer risk. We found that women who shared a bedroom as
children (and by implication were therefore, more likely to be
exposed to childhood infections) were less likely to have breast
cancer: age-adjusted odds ratio (95% confidence interval) compar-
ing those who shared a bedroom to those who did not 0.81 (0.59,
1.13), but bedroom sharing did not attenuate the association
between trunk length and breast cancer.
Trunk length will also be significantly influenced by lifetime
exposure to oestrogen and will be shorter because of osteoporotic
collapse in those with low levels of oestrogen exposure. Breast
cancer is oestrogen dependent, with risk being lower in those with
lower levels of exposure. Thus, the positive association between
trunk length and breast cancer may reflect the associations
between high levels of lifetime exposure to oestrogen and
decreased osteoporosis but increased breast cancer risk.
An alternative explanation for the association between trunk
length and breast cancer is that women with larger trunks may
have greater breast size. It has been hypothesised that breast size
predicts a woman’s risk of breast cancer because of increased
breast cell numbers, and both chest size (as indicated by bra size)
and breast size (as indicated by cup size) have been found to
predict breast cancer (Egan et al, 1999). Breast density, a marker of
cellularity of the breast, is related to breast cancer (Saftlas et al,
1991), suggesting that associations between measures of breast size
and breast cancer may reflect greater numbers of breast cells
leading to increased risk.
Birth weight
The association between birth weight and breast cancer risk most
likely reflects intrauterine exposures to maternal hormones that
influence both foetal growth and intrauterine development of the
mammary gland. Oestrogen would be one plausible hormone since
exposures to high levels of intrauterine oestrogen lead to increased
foetal size (Trichopoulos, 1990) and indictors of pregnancy
oestrogen concentrations have been shown to be associated with
breast cancer risk (Ekbom et al, 1992, 1997).
Implications
The associations between different measures of foetal and child-
hood growth most likely reflect differing intrauterine and child-
hood environmental risk factors for breast cancer. These findings
highlight the importance of foetal and early life exposures in the
aetiology of breast cancer. Further research should concentrate on
testing specific hypotheses concerning these associations as
outlined in Table 5.
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Table 5 Possible pathways underlying growth–breast cancer associa-
tions (adapted from Okasha et al., 2002)
Growth as a biomarker for other exposures that influence breast cancer risk
1. In utero exposures
Foetal nutrition is influenced by maternal steroids with greater exposure
resulting in greater foetal growth
Exposure to maternal steroids during breast development in utero may increase
cancer risk
2. Infections
Chronic infection may stunt growth – in particular trunk length
Absence of childhood infection may make individuals susceptible to infections,
which if acquired in later life are associated with cancer risk and may result in an
underdeveloped immune function
3. Calorie intake
Lower calorie intake in childhood results in shorter stature and in particular
shorter leg length
Lower incidence of cancer in rats fed a calorie-restricted diet
Childhood calorie intake may be related to adult cancer
Calorie intake may also influence growth-promoting hormones (see below)
Growth as a biomarker for biological mediators of risk
4. Cellularity
Greater trunk length may reflect a larger number of breast cells
A larger number of cells increases the risk that one will undergo malignant
transformation
5. Growth-promoting hormones
IGF is related to growth, particularly leg length
IGF is affected by nutritional intake during childhood
IGF is associated with cancer in animal studies although results from
epidemiological studies are inconsistent
6. Oestrogen
Low lifetime exposure to oestrogen will result in shorter trunk length because of
osteoporotic collapse
Later age at menarche will result in greater leg length and total height and may
be associated with reduced lifetime exposure to oestrogen
Breast cancer risk is associated with increased exposure to oestrogen
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